Less Than One-Fifth Of Medicare Enrollees With OUD Received MOUD Treatment

Of the 1.2 million Medicare enrollees with a diagnosis of opioid use disorder (OUD) in 2023, less than one-fifth (18.7%) were treated with medications for opioid use disorder (MOUD). The 2023 percentage receiving MOUD is similar to 2022, when 18.4% of Medicare enrollees with OUD received MOUD treatment.

Regionally, the share of beneficiaries with OUD who received MOUD ranged from 7% in Florida to 60% in Vermont:

Medicare enrollees in Florida (7%), Texas (8%), and Nevada (9%) continued to be the least likely to receive medication for their OUD

Enrollees in New England were most likely . . .